The Effects of Neuromuscular Training on Knee Biomechanics During Jump-Landing Among College Basketball Players Post ACL Reconstruction and Rehabilitation

January 6, 2026 updated by: Shazlin Shaharudin, Universiti Sains Malaysia

Basketball players often injure the anterior cruciate ligament (ACL), a key structure that stabilizes the knee. Even after surgery and standard rehabilitation, many athletes continue to have problems with knee stability, movement control, and performance during jumping and landing. These issues increase the risk of re-injury and can limit their ability to return to competition.

Neuromuscular training (NMT) is a type of exercise program that focuses on improving balance, muscle coordination, and movement patterns. It uses activities such as jump-landing drills, balance tasks, agility exercises, and core training. Previous research shows that NMT can help athletes land more safely, reduce harmful knee movements, and improve sport performance. However, little is known about its long-term benefits in college basketball players who are more than one year post-ACL surgery.

This study aims to evaluate whether a 12-week NMT program, added to standard basketball training, can improve knee biomechanics, stability, and performance in college basketball players with a history of ACL reconstruction. Thirty participants will be randomly assigned to either an NMT group or a control group. Both groups will complete basketball training, but only the NMT group will receive the additional neuromuscular exercises.

Knee movement will be measured using 3D motion capture and force plates, and performance will be tested through vertical jumps and other sport-specific tasks. The main outcomes will include knee angles during landing, ground reaction forces, dynamic stability, and jump height.

The expected outcome is that athletes who undergo NMT will demonstrate safer landing strategies, better knee control, and improved performance compared to those who only receive standard basketball training. These findings may help coaches and healthcare providers design safer, more effective rehabilitation programs for athletes after ACL surgery.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Hebei
      • Chengde, Hebei, China, 067000
        • Chengde Medical University, Affiliated Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:Male college basketball players

Age 18-25 years

History of anterior cruciate ligament (ACL) reconstruction surgery at least 12 months before enrollment

Cleared by physician for sports participation

Willing to provide informed consent and comply with study procedures

Exclusion Criteria:Previous ACL injury on the contralateral knee

Other major lower-limb injuries (e.g., meniscus, cartilage, fractures) in the past 12 months

Current knee pain, swelling, or instability that prevents safe participation

Neurological, cardiovascular, or systemic conditions that may affect training safety

Participation in another structured neuromuscular training program within the past 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neuromuscular Training (NMT) plus Standard Basketball Training
Participants in this arm will receive a 12-week neuromuscular training (NMT) program in addition to their regular basketball training. The NMT program will include balance tasks, jump-landing drills, agility exercises, and core strengthening. Sessions will be conducted in parallel with standard basketball practice.
The neuromuscular training (NMT) program is a 12-week behavioral intervention performed 2-3 times per week in addition to regular basketball training. It includes balance tasks, jump-landing drills, agility exercises, and core strengthening to improve knee stability and movement control after ACL reconstruction
No Intervention: Standard Basketball Training
Participants in this arm will continue their usual basketball training program for 12 weeks without additional neuromuscular training. Training content and schedule will follow standard team practice routines. This arm will serve as a comparator to evaluate the added effect of NMT.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak knee valgus angle during single-leg jump-landing (degrees)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Knee valgus angle will be measured using 3D motion capture during a standardized single-leg jump-landing task. The primary endpoint is the peak knee valgus angle (°) during the landing phase, averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to stabilization after landing (seconds)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Dynamic postural stability will be evaluated using force platform data during a standardized single-leg jump-landing task. The endpoint is time to stabilization (TTS, s) following landing, averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)
Center of pressure displacement after landing, medial-lateral (millimeters)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Center of pressure (COP) displacement will be quantified from force platform data during a standardized single-leg jump-landing task. The endpoint is COP displacement in the medial-lateral direction (mm), averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)
Peak knee flexion angle during single-leg jump-landing (degrees)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Peak knee flexion angle during the landing phase will be measured using 3D motion capture during a standardized single-leg jump-landing task. The endpoint is the peak knee flexion angle (°), averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)
Center of pressure displacement after landing, anterior-posterior (millimeters)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Center of pressure (COP) displacement will be quantified from force platform data during a standardized single-leg jump-landing task. The endpoint is COP displacement in the anterior-posterior direction (mm), averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)
Countermovement jump height (centimeters)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Explosive lower-limb power will be assessed using a countermovement jump (CMJ) on a force platform. The endpoint is jump height (cm) calculated from flight time, averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)
Squat jump height (centimeters)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Explosive lower-limb power will be assessed using a squat jump (SJ) on a force platform. The endpoint is jump height (cm) calculated from flight time, averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)
Knee flexion angle at initial contact during single-leg jump-landing (degrees)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Knee flexion angle at initial ground contact will be measured using 3D motion capture during a standardized single-leg jump-landing task. The endpoint is the knee flexion angle at initial contact (°), averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)
Peak vertical ground reaction force during single-leg jump-landing (Newtons)
Time Frame: Baseline (pre-intervention) and 12 weeks (post-intervention)
Vertical ground reaction force (vGRF) will be measured using force platforms during a standardized single-leg jump-landing task. The endpoint is peak vGRF (N) during landing, averaged across 3 successful trials.
Baseline (pre-intervention) and 12 weeks (post-intervention)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of prescribed neuromuscular training (NMT) sessions completed
Time Frame: Throughout the 12-week intervention period
Adherence will be assessed as the percentage of prescribed NMT sessions completed over the 12-week intervention period. A session will be considered completed if the participant attends and completes the full planned session.
Throughout the 12-week intervention period
Number of participants with ≥1 intervention-related adverse event
Time Frame: Throughout the 12-week intervention period
Safety will be assessed as the number of participants with ≥1 intervention-related adverse event during the 12-week intervention period.
Throughout the 12-week intervention period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 10, 2025

Primary Completion (Estimated)

March 5, 2026

Study Completion (Estimated)

May 15, 2026

Study Registration Dates

First Submitted

December 15, 2025

First Submitted That Met QC Criteria

December 30, 2025

First Posted (Estimated)

January 2, 2026

Study Record Updates

Last Update Posted (Actual)

January 7, 2026

Last Update Submitted That Met QC Criteria

January 6, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • USM/JEPeM/KK/25030307

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Injuries

Clinical Trials on Neuromuscular Training (NMT)

Subscribe